Stelis Biopharma Archives - Express Pharma

Syngene concludes acquisition of biologics facility from Stelis Biopharma

Syngene to acquire multi-modal facility from Stelis Biopharma

Stelis Biopharma’s facility receives EIR from USFDA

Stelis Biopharma gets EU cGMP accreditation for two biologics manufacturing facilities

Unable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs

RDIF, Stelis Biopharma join hands for 200 mn doses of Sputnik V vaccine

Stelis concludes $195 million Series B and Series C fund raise

HDFC founder, Aditya Puri joins Strides Group as Advisor and Director of Stelis Biopharma

Strides Board approves incremental investments in Stelis

Strides Shasun biotech arm receives $8.49 million investment from GMS Holdings